NEWTON, Mass.--(BUSINESS WIRE)--March 16, 2006--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate-based therapeutic compounds, today announced that the U.S. Patent & Trademark Office issued a new patent: No. 7,012,068, entitled: Co-Administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer. This is the fifth U.S. patent issued that covers the Company's proprietary carbohydrate compounds.
